Abiocor

AbioCor is an artificial heart developed by the Massachusetts-based company AbioMed. It is fully implantable within a patient, due to a combination of advances in miniaturization, biosensors, plastics and energy transfer that has made this advance possible. The AbioCor runs on a rechargeable source of power and is being tested in clinical trials in preparation for approval by the Food and Drug Administration.

Testing

As of September 2004, 14 patients have been implanted with the AbioCor heart. Most of these patients have passed away. For a patient to be eligible for implantation with the AbioCor, the person must have severe heart failure (with failure of both ventricles) and must be likely to die within two weeks without transplantation. The first patient to receive the AbioCor, Robert Tools, was implanted on July 2, 2001. He lived for 151 days before having a fatal cerebrovascular accident. Tom Christerson lived for 512 days after receiving the AbioCor, dying on February 7, 2003.

 

<< PreviousWord BrowserNext >>
administrative division of the komi republic
list of solo piano pieces by composer: t
coxiella burnetii
sergei akhromeev
formica rufa group
strange world
four color
telefon tel aviv
plum island (massachusetts)
screenshots
britain yearly meeting
findability
charles francis hall
formica rufa
mark attanasio
gennady yanayev
gitxsan nation
from beyond
relationship marketing
vladimir kryuchkov
the bloody chamber
historical development of church of england dioceses
virtual xi (album)
bobby digital
dmitriy yazov
electric eclipse
ascribed status
zx spectrum character set
ayaka komatsu
zong
pyword
beating a dead horse
cooloolidae
ainhumoid and mutilating keratodermia
ozzmosis
balassa samuelson effect
sylvia lynd
death watch
thorkelin
samuel dick
vermicious knids
military service of john kerry
hellmouth
microraptor